• FDA Advisors Back Fecal Microbiome Treatment for Recurrent C. Diff

    8 days ago - By MedPageToday

    An FDA advisory board recommended the agency approve a fecal microbiota transfer product for recurrent Clostridium difficile infections.
    By a vote of 13-4 on Thursday, the Vaccines and Related Biological Products Advisory...
    Read more ...